Bioactivity | αVβ8-IN-1 is a αVβ8 integrin inhibitor. αVβ8-IN-1 has been shown to inhibit the growth of tumors such as EMT6, CT26, KPC, and TKCC-10. αVβ8-IN-1 can be used in research related to idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP), and tumors[1]. |
CAS | 3048440-55-4 |
Formula | C25H32ClN5O4 |
Molar Mass | 502.01 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Machajewski, timothy D, et al. alpha-v-beta-8 integrin inhibitors and uses thereof. US2023/085812. 2024.07.04. |